Danish malaria vaccine passes test in humans
For many years, a team of researchers at the University of Copenhagen have been focussing on developing a vaccine that can protect against the disease pregnancy malaria from which 220,000 people die every year. Now they have come a significant step closer to being able to introduce such a vaccine in the market. In a new study published in the scientific journal Clinical Infectious Diseases the vaccine has been subjected to so-called phase one clinical trial, and the results are uplifting:
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Clinical Trials | Denmark Health | Infectious Diseases | Malaria | Malaria Vaccine | Pharmaceuticals | Pregnancy | Study | Vaccines